Analysis of Staged Treatment of Chronic Heart Failure Using the Warming and Suppressing Method

Corresponding author: Yang Fengjing, missfrank@126.com

DOI: 10.12201/bmr.202510.00061

•  

  Abstract: Chronic heart failure (CHF) represents the end-stage progression of cardiovascular diseases. Although modern medicine offers multi-target pharmacological interventions, challenges such as drug resistance and disease recurrence persist. Based on Professor Yang Fengjing’s theoretical perspective ofS“Yang governing Yin, with Yang consolidation ensuring stability”S at Wuhan Hospital of Traditional Chinese Medicine, this article proposes that the core pathogenesis of CHF involvesSdeficiency of Yang Qi,Sproliferation of pathogenic Yin, andSfloating of deficient Yang. It emphasizes the application of theSwarming and suppressing methodS as a pivotal strategy, combiningSwarming YangSandSsuppressing hyperactivitySto achieveS“Yin Ping Yang Mi”.The differential application of the warming and suppressing method is discussed according to the stage of Yang Qi consumption:During theScompensated stage, mild warming and suppressing are used to prevent progression;In theSdecompensated stage, strong warming and heavy suppressing are emphasized to eliminate turbid pathogens;At theSend stage, urgent revival of Yang and consolidation of genuine Yang are critical.A case example is included, demonstrating significant clinical outcomes and highlighting the advantages of integrating traditional Chinese and Western medicine in treating CHF. This approach provides an effective diagnostic and therapeutic framework for clinical practice.

  Key words: SChronic Heart Failure; Warming And Suppressing Method; Treatment By Stage; Proven Experience Of Distinguished Physicians

  Submit time: 31 October 2025

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Qiu Xiaoqin, Wei Jisi, Qiu Xinyu, Liu Na, Chen Sifan. Summary of the scope of symptom groups in patients with heart failure. 2025. doi: 10.12201/bmr.202501.00046

  LI JIE. Research Advances in Heart Failure with Preserved Ejection Fraction Complicated by Chronic Kidney Disease. 2025. doi: 10.12201/bmr.202504.00077

  The? Analysis of regulatory effects of? Health literacy between the burden of symptoms and disease uncertainty in patients with chronic heart failure?? Xue Qin dan, Chen Jie ru, Hu Bin mei, Wang Jin yu ,Chen Xiu qing. 2024. doi: 10.12201/bmr.202407.00062

  WU Xiayang. The mechanisms of action of SGLT2i in the treatment of heart failure and recent research advances. 2025. doi: 10.12201/bmr.202507.00052

  HAN Chenyuan. Analysis and evaluation of guideline-directed medical therapy in chronic heart failure inpatients with reduced ejection fraction in a third level hospital. 2025. doi: 10.12201/bmr.202507.00076

  The impact of evidence-based nutritional care on disease outcomes in patients with severe heart failure. 2025. doi: 10.12201/bmr.202503.00018

  paerhati·tuerxun. . 2025. doi: 10.12201/bmr.202507.00038

  CAO Jun, YANG Rongyuan, LIU Qing, LIU Qingyan. Bidirectional Two-Sample Mendelian Randomization Study of the Causal Relationship Between Asthma-related Pneumonia and Heart Failure. 2025. doi: 10.12201/bmr.202509.00016

  wang zhong. Plasma C1q/ tumor necrosis factor-associated protein 6 and systemic inflammatory response index levels in patients with heart failure and their clinical significance. 2025. doi: 10.12201/bmr.202501.00060

  Xu Ping¹. Exploration of Treatment Experience for Pediatric Atopic Dermatitis Based on Heart and Spleen Theory. 2024. doi: 10.12201/bmr.202412.00043

• ID	Submit time	Number	Download
  1	2025-10-26	10.12201/bmr.202510.00061V1	Download

• Public  Anonymous  To author only Submit Comments